Close Menu
    Madras GazetteMadras Gazette
    • Automotive
    • Business
    • Editorial
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Madras GazetteMadras Gazette
    Home » As COVID-19 cases soar again in China, cremations are rising
    Health

    As COVID-19 cases soar again in China, cremations are rising

    December 22, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The Chinese government has already prepared for an inevitable spike in deaths related to COVID-19 following the reversal of Beijing’s “zero-COVID” policy. In response to widespread protests, the government loosened its restrictions, which many in the country believe contributed to the death of ten people in a fire that occurred in a high-rise apartment building.

    As COVID-19 cases soar again in China, cremations are risingAs cases soared, China’s health care system was caught unprepared and scrambling to find beds and medicines to maintain clinics. There have been tens of thousands of fever clinics added to hospitals and even sports arenas in major cities throughout China, including Beijing, Shanghai, Chengdu, and Wenzhou. Asymptomatic cases are no longer reported by officials.

    Experts have already predicted that China could experience more than one million COVID-related deaths next year. According to Our World in Data, a spike occurred in March of this year with a rolling average of 26,570. The current wave peaked at 40,791 cases with a high of 62,439 on Dec. 2. Prior to the rollback of zero-COVID, WHO Emergencies Director Mike Ryan argued that “the control measures in themselves were not stopping the disease.”

    There is a significant lack of vaccinations in China, which contributes to the difficulty. As of December, China was delivering 100,000 to 200,000 doses per day. As of Dec. 13, that number had risen to more than 1.43 million. For years, China refused to adopt vaccines from the West. Instead, it relied on a vaccine called Sinopharm that doesn’t use mRNA models. These introduce antigen templates without exposing people to real viruses. Compared to older vaccine models, the more recent vaccines also scale and produce faster.

    China has approved the Pfizer-BioNTech vaccine for use, with the first batch being sent out Wednesday. There were no details on the size or timing of the delivery. Currently, the vaccine is only available to Germans living in China, but Beijing plans to use it for Chinese nationals as well. The country has around 20,000 Germans. As an exchange, Chinese citizens in Germany can receive SinoVac.

    Related Posts

    Ebola Bundibugyo outbreak expands health response in DRC

    May 16, 2026

    Measles outbreak in Bangladesh leaves toll at 415

    May 12, 2026

    Hantavirus probe deepens after deaths on Atlantic cruise

    May 4, 2026

    DR Congo lifts national mpox emergency after two years

    April 3, 2026

    UNICEF and partners launch $300m child nutrition drive

    March 13, 2026

    WHO IARC maps preventable cancer risks across 185 countries

    February 4, 2026
    Latest News

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026

    Japan and South Korea launch energy security framework

    May 20, 2026

    South Korea launches $665.5 million industrial growth fund

    May 20, 2026
    © 2026 Madras Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.